42 results
8-K
EX-99.1
VERV
Verve Therapeutics Inc
29 Nov 23
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
4:54pm
LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, New York, NY 10022, or by telephone at (877) 821-7388, or by email … at Prospectus_Department@Jefferies.com; Guggenheim Securities, LLC, Attention: Equity Syndicate Department, 330 Madison Avenue, 8th Floor, New York, NY 10017
8-K
EX-99.1
VERV
Verve Therapeutics Inc
21 Jul 22
Verve Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
4:46pm
: Equity Syndicate Prospectus Department, 520 Madison Avenue, New York, NY 10022, by telephone at 877-821-7388 or by email at prospectus_department … @Jefferies.com; Guggenheim Securities, LLC, Attention: Equity Syndicate Department, 330 Madison Avenue, New York, NY 10017, by telephone at (212) 518-5548
10-K
2021 FY
EX-10.14
VERV
Verve Therapeutics Inc
14 Mar 22
Annual report
7:04am
Control (“OFAC”) of the U.S. Department of Treasury and any statute, executive order, or regulation relating thereto (collectively, the “OFAC Rules
8-K
EX-1.1
rok3ep4x
29 Nov 23
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
4:54pm
S-3
EX-1.2
mkydanl
1 Jul 22
Shelf registration
4:36pm
8-K
EX-1.1
v7mlwj
21 Jul 22
Verve Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
4:46pm
S-1/A
EX-1.1
a58osj83o0tkd qpay
14 Jun 21
IPO registration (amended)
6:15am
DRS
EX-10.12
kq25rt0c0hv
16 Apr 21
Draft registration statement
12:00am
S-1
EX-10.11
9onpyrr2 mw7lfp8zg
28 May 21
IPO registration
4:04pm
S-1
EX-10.13
sk7dbt1j3 467o68xa9
28 May 21
IPO registration
4:04pm
DRS
EX-10.14
72gne b7m
16 Apr 21
Draft registration statement
12:00am
S-1
EX-10.1
luhoce37 d9
28 May 21
IPO registration
4:04pm
DRS
EX-10.1
a8i55i2
16 Apr 21
Draft registration statement
12:00am
S-1
EX-10.9
toj465s3 urk66zhwfb
28 May 21
IPO registration
4:04pm